PNC Financial Services Group
COGT icon

PNC Financial Services Group’s Cogent Biosciences COGT Stock Holding History

PNC Financial Services Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$75.9K Buy
2,371
+478
+25% +$17.7K ﹤0.01% 3136
2026
Q2 		$73.3K Buy
1,893
+460
+32% +$16.1K ﹤0.01% 3114
2026
Q1 		$55.2K Buy
1,433
+152
+12% +$5.61K ﹤0.01% 3168
2025
Q4 		$45.5K Buy
1,281
+1,032
+414% +$29K ﹤0.01% 3265
2025
Q3 		$3.58K Buy
249
+8
+3% +$95 ﹤0.01% 4328
2025
Q2 		$1.73K Buy
241
+177
+277% +$981 ﹤0.01% 4452
2025
Q1 		$383 Hold
64
– – ﹤0.01% 4687
2024
Q4 		$499 Hold
64
– – ﹤0.01% 4530
2024
Q3 		$691 Hold
64
– – ﹤0.01% 4517
2024
Q2 		$540 Buy
64
+44
+220% +$334 ﹤0.01% 4517
2024
Q1 		$134 Sell
20
-134
-87% -$828 ﹤0.01% 4638
2023
Q4 		$906 Buy
+154
New +$1.18K ﹤0.01% 4333

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

PNC Financial Services Group's COGT Position: Q3 2026 in Review

PNC Financial Services Group increased its Cogent Biosciences (COGT) stake by 25% in Q3 2026, buying an estimated $17.7K and bringing the position to 2,371 shares worth $75.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

PNC Financial Services Group first reported a position in COGT in Q4 2023 and has held it in 12 quarters since. 151 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • PNC Financial Services Group held 2,371 shares of Cogent Biosciences worth $75.9K as of Q3 2026.
  • PNC Financial Services Group bought 478 Cogent Biosciences shares in Q3 2026, an estimated $17.7K.
  • Cogent Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3136 holding.
  • PNC Financial Services Group first reported a position in Cogent Biosciences in Q4 2023 and has held it in 12 quarters since.
  • 151 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.